INS and type 2 diabetes mellitus: Umpierrez et al [8] compared BBT (glargine/glulisine) plus OHAs to sliding-scale regular insulin (SSI) in the inpatient management of with type 2 diabetic patients, mean daily insulin dose was about 42 U. Another comparison they made [9] was of inpatient insulin regimens with detemir plus aspart versus NPH plus regular in medical patients with type 2 diabetes.